Extracellular Vesicle‐Like Nanoparticles Present in Fermented Botanical Products Suppress Fat Absorption in the Gut

The fermented botanical product (FBP) is a complex, primarily plant-based fermented food that has been popular among consumers for many years. Although FBP may modulate gastrointestinal function, the responsible factors and precise mechanisms remain unclear and speculative. Extracellular vesicles (EVs) have gained widespread attention as a novel signaling system, not only in animals but also in plants and microorganisms. Here, we report that FBP contains EV-like nanoparticles composed of protein complexes originating from various lactic acid bacteria. When mice consumed the EV-like nanoparticle-enriched fraction of FBP as a beverage for three weeks, their body weight gain was reduced by up to approximately 10%, particularly in those fed a high-fat/high-sucrose (HF/HS) diet. Although the HF/HS diet induced colonic atrophy in mice, the ingestion of the EV-like nanoparticles-enriched fraction of FBP increased lipid efflux in feces by more than two-fold and improved the pathological images of the colon. In vitro experiments on lipase activity suggested lipase inhibitory activity in the EV-like nanoparticle-enriched fraction of FBP. Compound analyses revealed that ferulic acid was enriched in the EV-like nanoparticle fraction and inhibited lipase activity in vitro. The biological effects observed in this study were attenuated by reducing the amount of EV-like nanoparticles using a polytetrafluoroethylene (PTFE) membrane. However, the slight reduction (not statistically significant) in bioactivity in the PTFE-treated group compared with the polyether sulfone (PES) treated group, despite a marked decrease in ferulic acid content, suggests the possible involvement of additional molecules beyond EV-like nanoparticles in this fraction. These findings indicate that FBP may serve as a potential therapeutic option for obesity and gastric symptoms. PRACTICAL APPLICATIONS: Extracellular vesicle-like nanoparticles in FBP may support health by alleviating obesity through the suppression of excessive intestinal lipid uptake. These findings suggest that FBP could be developed into a functional food or supplement for individuals who frequently consume high-fat diets.

Authors

Institutions

Publication Details

Journal
Journal of Food Science
Published
2025-08-28
DOI
https://doi.org/10.1111/1750-3841.70518
Citations
1
Primary Topic
Extracellular vesicles in disease
Type
article
Field-Weighted Citation Impact
0.81
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Extracellular Vesicle‐Like Nanoparticles Present in Fermented Botanical Products Suppress Fat Absorption in the Gut

Kotaro Fujioka, Ayano Hojo, Hiroshi Takemori, Chika Yamamoto et al.
1 citations
Journal of Food Science
Extracellular vesicles in disease
0.81
article

Extracellular Vesicle‐Like Nanoparticles Present in Fermented Botanical Products Suppress Fat Absorption in the Gut

Kotaro Fujioka, Ayano Hojo, Hiroshi Takemori, Chika Yamamoto, Hideto Torii, Kotomi Chikama, Lee Wah Lim, Mana Yamamoto, Kensuke Terada
article en
1 citations

Abstract

The fermented botanical product (FBP) is a complex, primarily plant-based fermented food that has been popular among consumers for many years. Although FBP may modulate gastrointestinal function, the responsible factors and precise mechanisms remain unclear and speculative. Extracellular vesicles (EVs) have gained widespread attention as a novel signaling system, not only in animals but also in plants and microorganisms. Here, we report that FBP contains EV-like nanoparticles composed of protein complexes originating from various lactic acid bacteria. When mice consumed the EV-like nanoparticle-enriched fraction of FBP as a beverage for three weeks, their body weight gain was reduced by up to approximately 10%, particularly in those fed a high-fat/high-sucrose (HF/HS) diet. Although the HF/HS diet induced colonic atrophy in mice, the ingestion of the EV-like nanoparticles-enriched fraction of FBP increased lipid efflux in feces by more than two-fold and improved the pathological images of the colon. In vitro experiments on lipase activity suggested lipase inhibitory activity in the EV-like nanoparticle-enriched fraction of FBP. Compound analyses revealed that ferulic acid was enriched in the EV-like nanoparticle fraction and inhibited lipase activity in vitro. The biological effects observed in this study were attenuated by reducing the amount of EV-like nanoparticles using a polytetrafluoroethylene (PTFE) membrane. However, the slight reduction (not statistically significant) in bioactivity in the PTFE-treated group compared with the polyether sulfone (PES) treated group, despite a marked decrease in ferulic acid content, suggests the possible involvement of additional molecules beyond EV-like nanoparticles in this fraction. These findings indicate that FBP may serve as a potential therapeutic option for obesity and gastric symptoms. PRACTICAL APPLICATIONS: Extracellular vesicle-like nanoparticles in FBP may support health by alleviating obesity through the suppression of excessive intestinal lipid uptake. These findings suggest that FBP could be developed into a functional food or supplement for individuals who frequently consume high-fat diets.

Journal of Food ScienceVol. 90(9)
Gifu University (JP), Onomichi City University (JP)
Openalex Percentile: Top 24%
Extracellular vesicles in disease
0.81
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.